IRIS Accounts Production v26.1.10.61 05773858 Board of Directors 1.1.25 31.12.25 31.12.25 Medium entities the provision of residential care services. true false true true false false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh057738582024-12-31057738582025-12-31057738582025-01-012025-12-31057738582023-12-31057738582024-01-012024-12-31057738582024-12-3105773858ns15:EnglandWales2025-01-012025-12-3105773858ns14:PoundSterling2025-01-012025-12-3105773858ns10:Director12025-01-012025-12-3105773858ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3105773858ns10:MediumEntities2025-01-012025-12-3105773858ns10:Audited2025-01-012025-12-3105773858ns10:Medium-sizedCompaniesRegimeForDirectorsReport2025-01-012025-12-3105773858ns10:Medium-sizedCompaniesRegimeForAccounts2025-01-012025-12-3105773858ns10:FullAccounts2025-01-012025-12-310577385812025-01-012025-12-3105773858ns10:OrdinaryShareClass12025-01-012025-12-3105773858ns10:Director22025-01-012025-12-3105773858ns10:Director32025-01-012025-12-3105773858ns10:CompanySecretary12025-01-012025-12-3105773858ns10:RegisteredOffice2025-01-012025-12-310577385812025-01-012025-12-310577385812024-01-012024-12-3105773858ns5:CurrentFinancialInstruments2025-12-3105773858ns5:CurrentFinancialInstruments2024-12-3105773858ns5:Non-currentFinancialInstruments2025-12-3105773858ns5:Non-currentFinancialInstruments2024-12-3105773858ns5:ShareCapital2025-12-3105773858ns5:ShareCapital2024-12-3105773858ns5:RevaluationReserve2025-12-3105773858ns5:RevaluationReserve2024-12-3105773858ns5:RetainedEarningsAccumulatedLosses2025-12-3105773858ns5:RetainedEarningsAccumulatedLosses2024-12-3105773858ns5:ShareCapital2023-12-3105773858ns5:RetainedEarningsAccumulatedLosses2023-12-3105773858ns5:RevaluationReserve2023-12-3105773858ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-3105773858ns5:RevaluationReserve2024-01-012024-12-3105773858ns5:RetainedEarningsAccumulatedLosses2025-01-012025-12-3105773858ns5:RevaluationReserve2025-01-012025-12-310577385812025-01-012025-12-3105773858ns5:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3105773858ns5:FurnitureFittings2025-01-012025-12-3105773858ns5:MotorVehicles2025-01-012025-12-3105773858ns5:ComputerEquipment2025-01-012025-12-3105773858ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2025-01-012025-12-3105773858ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2024-01-012024-12-3105773858ns5:OwnedAssets2025-01-012025-12-3105773858ns5:OwnedAssets2024-01-012024-12-3105773858ns5:LeasedAssets2025-01-012025-12-3105773858ns5:LeasedAssets2024-01-012024-12-3105773858ns5:NetGoodwill2025-01-012025-12-3105773858ns5:NetGoodwill2024-01-012024-12-3105773858ns5:HirePurchaseContracts2025-01-012025-12-3105773858ns5:HirePurchaseContracts2024-01-012024-12-3105773858ns10:OrdinaryShareClass12024-01-012024-12-3105773858ns5:NetGoodwill2024-12-3105773858ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3105773858ns5:PatentsTrademarksLicencesConcessionsSimilar2025-01-012025-12-3105773858ns5:NetGoodwill2025-12-3105773858ns5:PatentsTrademarksLicencesConcessionsSimilar2025-12-3105773858ns5:NetGoodwill2024-12-3105773858ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3105773858ns5:LandBuildings2024-12-3105773858ns5:FurnitureFittings2024-12-3105773858ns5:MotorVehicles2024-12-3105773858ns5:ComputerEquipment2024-12-3105773858ns5:LandBuildings2025-01-012025-12-3105773858ns5:LandBuildings2025-12-3105773858ns5:FurnitureFittings2025-12-3105773858ns5:MotorVehicles2025-12-3105773858ns5:ComputerEquipment2025-12-3105773858ns5:LandBuildings2024-12-3105773858ns5:FurnitureFittings2024-12-3105773858ns5:MotorVehicles2024-12-3105773858ns5:ComputerEquipment2024-12-3105773858ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2024-12-3105773858ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-01-012025-12-3105773858ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-12-3105773858ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2024-12-3105773858ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3105773858ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3105773858ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-12-3105773858ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-12-3105773858ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-12-3105773858ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-12-3105773858ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2025-12-3105773858ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-12-3105773858ns5:HirePurchaseContractsns5:BetweenOneFiveYears2025-12-3105773858ns5:HirePurchaseContractsns5:BetweenOneFiveYears2024-12-3105773858ns5:HirePurchaseContracts2025-12-3105773858ns5:HirePurchaseContracts2024-12-3105773858ns5:WithinOneYear2025-12-3105773858ns5:WithinOneYear2024-12-3105773858ns5:BetweenOneFiveYears2025-12-3105773858ns5:BetweenOneFiveYears2024-12-3105773858ns5:AllPeriods2025-12-3105773858ns5:AllPeriods2024-12-3105773858ns5:Secured2025-12-3105773858ns5:Secured2024-12-3105773858ns5:AcceleratedTaxDepreciationDeferredTax2025-12-3105773858ns5:AcceleratedTaxDepreciationDeferredTax2024-12-3105773858ns5:DeferredTaxation2024-12-3105773858ns5:DeferredTaxation2025-12-3105773858ns10:OrdinaryShareClass12025-12-3105773858ns5:RetainedEarningsAccumulatedLosses2024-12-3105773858ns5:RevaluationReserve2024-12-3105773858ns10:Director112024-12-3105773858ns10:Director112023-12-3105773858ns10:Director112025-01-012025-12-3105773858ns10:Director112024-01-012024-12-3105773858ns10:Director112025-12-3105773858ns10:Director112024-12-31
REGISTERED NUMBER: 05773858 (England and Wales)















STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

NORTHGATE HEALTHCARE LIMITED

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025




Page

Company Information 1

Strategic Report 2

Report of the Directors 5

Report of the Independent Auditors 7

Income Statement 11

Other Comprehensive Income 12

Balance Sheet 13

Statement of Changes in Equity 14

Cash Flow Statement 15

Notes to the Cash Flow Statement 16

Notes to the Financial Statements 17


NORTHGATE HEALTHCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2025







DIRECTORS: A K Haines
K Haines
M K Haines





SECRETARY: A K Haines





REGISTERED OFFICE: White Gables
Cross Lane Head
Bridgnorth
Shropshire
WV16 4SJ





REGISTERED NUMBER: 05773858 (England and Wales)





AUDITORS: Muras Baker Jones Limited
Chartered Accountants and Statutory Auditors
Regent House
Bath Avenue
Wolverhampton
West Midlands
WV1 4EG

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025

The directors present their strategic report for the year ended 31 December 2025.

We aim to present a balanced and comprehensive review of our business's development and performance during the year and its position at the year-end. Our review reflects the size and non-complex nature of our business and is written in the context of the risks and uncertainties we face.


NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025

REVIEW OF BUSINESS
Northgate Healthcare provides residential and nursing care homes for the elderly. We currently own and operate five homes across the Midlands. We manage and assess each home individually to ensure performance is measured effectively.

We pride ourselves on the quality of our homes and the care we provide. Within our group of five homes, we provide nursing care, specialist dementia care and residential care. Nursing care is provided at both Autumn House and Ashcroft Hollow, which also provide specialist dementia and residential care along with our other three homes.

As part of our growth strategy, we continue to explore acquisition opportunities. However, during 2025 we were unable to find a suitable acquisition that meets the Northgate ethos.

All of our homes were profitable in 2025, except our newest home, Ashcroft Hollow, which has been undergoing refurbishment when occupancy allows and results in 2026 are positive. The remainder of the homes and the group as a whole are profitable during 2026. Total turnover rose compared with 2024, driven by higher fees and occupancy rates.

We have continued with the ongoing program of repairs to all homes to ensure they are kept to the high standards which we continue to meet for all of our service users. This again has resulted in a higher than average spend on repairs and maintenance at The Firs and Meadowfields, but it reflects the high standards we endeavor to maintain across the Northgate Group. The refurbishment of Autumn House finished in 2025 with the home showing better occupancy as a result.The refurbishment of Ashcroft Hollow was ongoing during the year to ensure the home meets the high standards expected across the Northgate group. We expect overall maintenance expenditure to decrease across the other homes in 2026, apart from the usual cyclical refurbishment programme. We are planning an extension on Ashcroft Hollow for which planning has been granted and this is planned for the latter part of 2026 and 2027.

Nursing care is a growing sector within the industry and the directors are satisfied that including this service at both Autumn House and now Ashcroft Hollow is worthwhile to the Northgate Healthcare group. This will ensure Northgate Healthcare can continue to provide residents with the level of care they require as their needs change.

Our staff are at the heart of the care we provide, and their dedication is central to our success. We recognise that attracting and retaining high-quality staff in the care sector remains a challenge. To support retention, we implemented wage increases in April 2025 and 2026 to remain competitive and to reward staff for their commitment. We also continue to invest in training and professional development to ensure our teams are skilled, motivated, and able to deliver the highest standard of care. To ensure staff wellbeing remains a top priority, we offer a health and wellbeing programme for staff employed over six months. This allows them 24/7 access to a GP and other support networks. This demonstrates our commitment to supporting our employees.

We are proud to maintain strong staff retention levels across our homes, which directly contributes to consistency of care, high resident satisfaction, and improved overall performance. By offering career progression, ongoing training, and a supportive working environment, we ensure our workforce feels valued and engaged.

We consider the key financial performance indicators to be those that communicate the financial performance and strength of the company as a whole, these being average occupancy rates, gross profit margin and earnings before interest, tax, depreciation and amortisation (EBITDA).

Occupancy levels improved in 2025 compared with 2024, and we are confident that this trend will continue in 2026, particularly as Ashcroft Hollow continues to build occupancy throughout the year. Resident retention and satisfaction remain high across all homes.

The company's gross profit margin is similar to 2024, at 38.96% compared to 39.99% in 2024. This is a testament to both the high standards of the homes and the care provided to our residents.

Following the new measures introduced a couple of years ago, which have continued since, this has helped achieve higher occupancy rates and better profitability across all homes in the group, with both occupancy rates and profitability increasing overall.


NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025

PRINCIPAL RISKS AND UNCERTAINTIES
The company continues to face a few external risks that could impact operations and financial performance, including:

- The effects of a further economic downturn, which could lead to further pressures on margins
- Changes in the availability of public sector funding, as a proportion of residents rely on government contributions to meet care fees.
- Changes to healthcare visas, which could lead to employment shortages throughout the sector.

With these risks and uncertainties in mind, we are aware that any plans for the future development of the business may be subject to unforeseen events outside of our control.

FINANCIAL RISK MANAGEMENT
The company's credit risk is low, being primarily attributed to its trade debtors. The company manages all credit risk, both publicly and privately funded, by monitoring payments against contractual agreements. With interest rates continuing to fall during 2025, interest costs have been lower than in 2024, but loans were renegotiated during 2026, so we expect interest costs to fall further in the current year. This has supported profitability for the year and other measures have driven an overall increase in profitability. The directors continue to manage increased costs to support continued profitability.

The company faces financial risk from the inflationary pressures on staff costs. Any future changes in the National Living Wage will have a significant impact on labour costs in the care sector as a whole. The company reviews upcoming changes to the National Living Wage and currently pays above this rate to ensure good quality care staff. The company plans future wage increases to ensure the financial stability of the company going forward and to ensure these increases do not overly impact cash flow and profitability.

ON BEHALF OF THE BOARD:





A K Haines - Director


10 September 2026

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2025

The directors present their report with the financial statements of the company for the year ended 31 December 2025.

DIVIDENDS
The total distribution of dividends for the year ended 31 December 2025 will be £ 811,419 .

FUTURE DEVELOPMENTS
The directors are confident about the continuing financial performance of the business and continue to seek opportunities to develop the business further.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2025 to the date of this report.

A K Haines
K Haines
M K Haines

OUR PEOPLE
The company provides employees with information on matters of concern to them, consulting them regularly so that their views can be taken into account when making decisions that are likely to affect their interests.

DISABLED EMPLOYEES
The company is committed to a policy of recruitment and promotion based on the basis of aptitude and ability without discrimination of any kind. Particular attention is given to the training and promotion of disabled employees to ensure that their career development is not unfairly restricted by their disability, or perceptions to it.

The HR procedures make clear that full and fair consideration must be given to applications made by and the promotion of disabled persons. Where an employee becomes disabled whilst employed by the company, the HR procedures also require that reasonable effort is made to ensure they have the opportunity for continued employment within the company. Retaining of employees who become disabled whilst employed by the company is offered where appropriate.

DISCLOSURE IN THE STRATEGIC REPORT
A review of the business, principle risks and uncertainties and financial risk management are included in the Strategic Report.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2025


STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, Muras Baker Jones Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





A K Haines - Director


10 September 2026

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
NORTHGATE HEALTHCARE LIMITED

Opinion
We have audited the financial statements of Northgate Healthcare Limited (the 'company') for the year ended 31 December 2025 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
NORTHGATE HEALTHCARE LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page five, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
NORTHGATE HEALTHCARE LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from
material misstatement, whether due to fraud or error, and to issue a Report of the Independent Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

In planning and designing our audit tests we identify and assess the risks of material misstatement within the financial
statements, whether due to fraud or error. Our assessment of these risks includes consideration of the nature of the
industry and sector, the control environment and the business performance along with the results of our enquiries of
management about their own identification and assessment of risks and irregularities. In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override. We also obtained an understanding of the legal and regulatory frameworks that the company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included the UK Companies Act, UK tax legislation and other laws and regulations identified as risk areas identified from our discussions with management.

We communicated relevant identified laws and regulations and potential fraud risks to all engagement team members including internal specialists, and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

After consideration of the above risks we then carried out audit procedures including the following:

- specific tests in relation to material amounts and disclosures in the financial statements considered to be of high risk;
- performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;
- reading minutes of management meetings;
- reviewing correspondence with H M Revenue & Customs;
- enquiring of management and reviewing any correspondence with legal advisors concerning actual and potential
litigation and claims;
- reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with
provisions of relevant laws and regulations described as having a direct effect on the financial statements;
- in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.

There are inherent limitations in our audit procedures described above. The more removed that the laws and regulations are from financial transactions the less likely it is that we would be aware on non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any. Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's report.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
NORTHGATE HEALTHCARE LIMITED


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Nicky Gibbons BSc (Hons) FCA (Senior Statutory Auditor)
for and on behalf of Muras Baker Jones Limited
Chartered Accountants and Statutory Auditors
Regent House
Bath Avenue
Wolverhampton
West Midlands
WV1 4EG

10 September 2026

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

INCOME STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2025

2025 2024
Notes £    £   

TURNOVER 14,365,691 13,334,975

Cost of sales (8,769,160 ) (8,001,921 )
GROSS PROFIT 5,596,531 5,333,054

Administrative expenses (2,047,386 ) (2,290,032 )
OPERATING PROFIT 4 3,549,145 3,043,022

Interest receivable and similar income 18,006 31,650
3,567,151 3,074,672

Interest payable and similar expenses 5 (441,377 ) (524,791 )
PROFIT BEFORE TAXATION 3,125,774 2,549,881

Tax on profit 6 (676,059 ) (630,255 )
PROFIT FOR THE FINANCIAL YEAR 2,449,715 1,919,626

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2025

2025 2024
Notes £    £   

PROFIT FOR THE YEAR 2,449,715 1,919,626


OTHER COMPREHENSIVE INCOME
Revaluation surplus - (134,975 )
Income tax relating to other comprehensive
income

-

-
OTHER COMPREHENSIVE INCOME
FOR THE YEAR, NET OF INCOME TAX

-

(134,975

)
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

2,449,715

1,784,651

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

BALANCE SHEET
31 DECEMBER 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 8 16,001 32,000
Tangible assets 9 16,109,976 16,031,740
16,125,977 16,063,740

CURRENT ASSETS
Stocks 10 31,198 29,712
Debtors 11 1,841,750 1,660,743
Cash at bank and in hand 3,011,222 2,045,402
4,884,170 3,735,857
CREDITORS
Amounts falling due within one year 12 2,352,886 2,384,158
NET CURRENT ASSETS 2,531,284 1,351,699
TOTAL ASSETS LESS CURRENT
LIABILITIES

18,657,261

17,415,439

CREDITORS
Amounts falling due after more than one
year

13

(6,124,585

)

(6,525,614

)

PROVISIONS FOR LIABILITIES 17 (1,960,551 ) (1,955,996 )
NET ASSETS 10,572,125 8,933,829

CAPITAL AND RESERVES
Called up share capital 18 100 100
Revaluation reserve 19 4,468,122 4,468,122
Retained earnings 19 6,103,903 4,465,607
SHAREHOLDERS' FUNDS 10,572,125 8,933,829

The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2026 and were signed on its behalf by:





A K Haines - Director


NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025

Called up
share Retained Revaluation Total
capital earnings reserve equity
£    £    £    £   
Balance at 1 January 2024 100 3,255,929 4,603,097 7,859,126

Changes in equity
Dividends - (709,948 ) - (709,948 )
Total comprehensive income - 1,919,626 (134,975 ) 1,784,651
Balance at 31 December 2024 100 4,465,607 4,468,122 8,933,829

Changes in equity
Dividends - (811,419 ) - (811,419 )
Total comprehensive income - 2,449,715 - 2,449,715
Balance at 31 December 2025 100 6,103,903 4,468,122 10,572,125

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2025

2025 2024
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 3,703,471 3,804,774
Interest paid (428,738 ) (512,094 )
Interest element of hire purchase payments
paid

(12,639

)

(12,697

)
Tax paid (837,744 ) (589,279 )
Net cash from operating activities 2,424,350 2,690,704

Cash flows from investing activities
Purchase of tangible fixed assets (275,468 ) (142,683 )
Interest received 18,006 31,650
Net cash from investing activities (257,462 ) (111,033 )

Cash flows from financing activities
Loan repayments in year (400,433 ) (331,991 )
Inter company loan (370,803 ) (684,630 )
Capital repayments in year 81,745 (30,309 )
Amount introduced by directors 300,563 -
Amount withdrawn by directors (721 ) (297,707 )
Equity dividends paid (811,419 ) (709,948 )
Net cash from financing activities (1,201,068 ) (2,054,585 )

Increase in cash and cash equivalents 965,820 525,086
Cash and cash equivalents at beginning of
year

2

2,045,402

1,520,316

Cash and cash equivalents at end of year 2 3,011,222 2,045,402

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2025

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

2025 2024
£    £   
Profit before taxation 3,125,774 2,549,881
Depreciation charges 174,223 178,626
Loss on disposal of fixed assets 39,008 -
Finance costs 441,377 524,791
Finance income (18,006 ) (31,650 )
3,762,376 3,221,648
Increase in stocks (1,486 ) (1,813 )
(Increase)/decrease in trade and other debtors (97,499 ) 352,581
Increase in trade and other creditors 40,080 232,358
Cash generated from operations 3,703,471 3,804,774

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 December 2025
31.12.25 1.1.25
£    £   
Cash and cash equivalents 3,011,222 2,045,402
Year ended 31 December 2024
31.12.24 1.1.24
£    £   
Cash and cash equivalents 2,045,402 1,520,316


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.1.25 Cash flow At 31.12.25
£    £    £   
Net cash
Cash at bank and in hand 2,045,402 965,820 3,011,222
2,045,402 965,820 3,011,222
Debt
Finance leases (159,146 ) (81,745 ) (240,891 )
Debts falling due within 1 year (331,990 ) (68,444 ) (400,434 )
Debts falling due after 1 year (6,394,321 ) 468,877 (5,925,444 )
(6,885,457 ) 318,688 (6,566,769 )
Total (4,840,055 ) 1,284,508 (3,555,547 )

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1. STATUTORY INFORMATION

Northgate Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Critical accounting judgements and key sources of estimation uncertainty
In order to properly apply the company’s accounting policies, as described in note 1 above, the directors are required to make judgements and estimates in respect of carrying values of assets and liabilities which may not be apparent from other sources of information. The directors base these critical accounting judgements and estimations on previous historical experience and other factors which the directors judge to be relevant. Judgements and estimates will invariably differ from actual results and hence such judgements and estimates are reviewed by the directors on an ongoing basis.

Key sources of estimation uncertainty

The key sources of estimation uncertainty which have a significant effect on the amounts recognised in the financial statements are described below:

Property valuation
The care homes owned by the company have been revalued on a regular basis, the latest of these being based on professional valuations prepared in 2024 on two of the homes with the remaining two being in 2022. These have been reviewed each year by the directors. Although this complies with the relevant accounting standards there is a possibility that the realisable value of the homes may differ to the values used in the event of a sale.

Turnover
Turnover represents the fees derived from the provision of care services to residents during the year. Income is recognised on a daily basis for the provision of nursing care services.

Goodwill
Goodwill, being the amount paid in connection with acquisition of care homes in 2007, 2010, 2015 and 2017 is being amortised evenly over its estimated useful economic life of 10 years. An annual impairment review has been carried out on the carrying value of goodwill and an adjustment is made where necessary.

Intangible assets
Intellectual property rights and books of account, being the amount paid in connection with the acquisition of a care home in 2010, are is being amortised evenly over its estimated useful economic life of 10 years. An annual impairment review has been carried out on the carrying value and an adjustment is made where necessary.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Fixtures fittings & equipment - 10% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

2. ACCOUNTING POLICIES - continued

Financial instruments
(i) Cash and cash Equivalents
Cash and cash equivalents are basic financial instruments and include cash in hand, deposits held at call with banks, and bank overdrafts.
(ii) Debtors and creditors receivable/payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are stated at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS
2025 2024
£    £   
Wages and salaries 7,321,916 6,861,249
Social security costs 730,077 494,275
Other pension costs 251,552 219,419
8,303,545 7,574,943

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

3. EMPLOYEES AND DIRECTORS - continued

The average number of employees during the year was as follows:
2025 2024

Lane House 47 47
The Firs 99 113
Meadowfields 93 89
Autumn House 110 115
349 364

2025 2024
£    £   
Directors' remuneration 21,125 21,125
Directors' pension contributions to money purchase schemes 120,000 100,000

4. OPERATING PROFIT

The operating profit is stated after charging:

2025 2024
£    £   
Hire of plant and machinery 48,058 53,515
Other operating leases 6,000 5,200
Depreciation - owned assets 89,327 87,717
Depreciation - assets on hire purchase contracts 68,897 41,756
Loss on disposal of fixed assets 39,008 -
Goodwill amortisation 15,999 49,153
Auditors' remuneration 13,251 9,300

5. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£    £   
Bank loan interest 428,738 508,302
Other interest - 3,792
Hire purchase 12,639 12,697
441,377 524,791

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2025 2024
£    £   
Current tax:
UK corporation tax 688,365 621,605
Amendment to prior year due to capital allowances
claim

(16,861

)

-
Total current tax 671,504 621,605

Deferred tax 4,555 8,650
Tax on profit 676,059 630,255

UK corporation tax has been charged at 25% (2024 - 25%).

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£    £   
Profit before tax 3,125,774 2,549,881
Profit multiplied by the standard rate of corporation tax in the UK of 25%
(2024 - 25%)

781,444

637,470

Effects of:
Expenses not deductible for tax purposes 2,970 5,660
Capital allowances in excess of depreciation (4,555 ) (8,650 )
Adjustments to tax charge in respect of previous periods (16,861 ) -
Deferred tax movement per note 17 4,555 8,650
Group loss relief (91,494 ) (12,875 )
Total tax charge 676,059 630,255

Tax effects relating to effects of other comprehensive income

There were no tax effects for the year ended 31 December 2025.

2024
Gross Tax Net
£    £    £   
Revaluation surplus (134,975 ) - (134,975 )

7. DIVIDENDS
2025 2024
£    £   
Interim 811,419 709,948

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

8. INTANGIBLE FIXED ASSETS
Intellectual
property
Goodwill & books Totals
£    £    £   
COST
At 1 January 2025
and 31 December 2025 1,484,026 12,507 1,496,533
AMORTISATION
At 1 January 2025 1,452,027 12,506 1,464,533
Amortisation for year 15,999 - 15,999
At 31 December 2025 1,468,026 12,506 1,480,532
NET BOOK VALUE
At 31 December 2025 16,000 1 16,001
At 31 December 2024 31,999 1 32,000

9. TANGIBLE FIXED ASSETS
Fixtures
Freehold fittings Motor Computer
property & equipment vehicles equipment Totals
£    £    £    £    £   
COST OR VALUATION
At 1 January 2025 15,153,684 1,506,678 271,122 26,714 16,958,198
Additions 17,674 77,212 168,818 11,764 275,468
Disposals - (125,134 ) - (10,358 ) (135,492 )
At 31 December 2025 15,171,358 1,458,756 439,940 28,120 17,098,174
DEPRECIATION
At 1 January 2025 - 772,224 135,864 18,370 926,458
Charge for year - 77,324 76,019 4,881 158,224
Eliminated on disposal - (86,710 ) - (9,774 ) (96,484 )
At 31 December 2025 - 762,838 211,883 13,477 988,198
NET BOOK VALUE
At 31 December 2025 15,171,358 695,918 228,057 14,643 16,109,976
At 31 December 2024 15,153,684 734,454 135,258 8,344 16,031,740

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

9. TANGIBLE FIXED ASSETS - continued

Cost or valuation at 31 December 2025 is represented by:

Fixtures
Freehold fittings Motor Computer
property & equipment vehicles equipment Totals
£    £    £    £    £   
Valuation in 2010 672,989 - - - 672,989
Valuation in 2013 979,584 - - - 979,584
Valuation in 2016 2,271,396 - - - 2,271,396
Valuation in 2022 1,906,817 - - - 1,906,817
Valuation in 2024 (163,227 ) - - - (163,227 )
Cost 9,503,799 1,458,756 439,940 28,120 11,430,615
15,171,358 1,458,756 439,940 28,120 17,098,174

If freehold land and buildings had not been revalued they would have been included at the following historical cost:

2025 2024
£    £   
Cost 9,503,799 9,486,125

Lane House Residential Care Home and The Firs Residential Care Home were revalued on an open market basis on 1st August 2024 by Colliers International Property Consultants Limited.

Meadowfields Residential Care Home and Autumn House Nursing Home were revalued on 7th October 2022 by Colliers International Valuation UK LLP

The freehold properties were valued as fully equipped operational entities, having regard to their trading potential.

The property values were reviewed by the Directors as at 31 December 2025. The Directors have many years experience in the care home industry and therefore consider themselves in a proper position to make this review. In their opinion the market value of the all properties above has not materially altered since the date of the independent valuations.

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

9. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
COST OR VALUATION
At 1 January 2025 222,702
Additions 150,318
At 31 December 2025 373,020
DEPRECIATION
At 1 January 2025 97,432
Charge for year 68,897
At 31 December 2025 166,329
NET BOOK VALUE
At 31 December 2025 206,691
At 31 December 2024 125,270

10. STOCKS
2025 2024
£    £   
Stocks - food and medical
supplies 31,198 29,712

11. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 767,177 620,000
Amounts owed by group undertakings 1,051,965 681,162
Other debtors 20,188 17,046
Directors' current accounts - 287,295
Prepayments 2,420 55,240
1,841,750 1,660,743

12. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts (see note 14) 400,434 331,990
Hire purchase contracts (see note 15) 41,750 27,853
Trade creditors 449,574 440,327
Tax 255,365 421,605
Social security and other taxes 152,687 120,752
Other creditors 614,493 557,509
Directors' current accounts 13,053 506
Accruals and deferred income 425,530 483,616
2,352,886 2,384,158

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

13. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans (see note 14) 5,925,444 6,394,321
Hire purchase contracts (see note 15) 199,141 131,293
6,124,585 6,525,614

14. LOANS

An analysis of the maturity of loans is given below:

2025 2024
£    £   
Amounts falling due within one year or on demand:
Bank loans 400,434 331,990

Amounts falling due between one and two years:
Bank loans - 1-2 years 400,434 331,990

Amounts falling due between two and five years:
Bank loans - 2-5 years 5,525,010 6,062,331

15. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase
contracts
2025 2024
£    £   
Net obligations repayable:
Within one year 41,750 27,853
Between one and five years 199,141 131,293
240,891 159,146

Non-cancellable
operating leases
2025 2024
£    £   
Within one year 19,904 23,667
Between one and five years 21,562 41,446
41,466 65,113

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

16. SECURED DEBTS

The following secured debts are included within creditors:

2025 2024
£    £   
Bank loans 6,325,878 6,726,311
Hire purchase contracts 240,891 159,146
6,566,769 6,885,457

A first legal charge and debenture on freehold property known as Lane House, Lichfield Road, Tamworth, Staffordshire, The Firs, Wodehouse Lane, Sedgley, West Midlands, Meadowfields Residential Care Home, Great Haywood, Stafford and land on the north west and south east side of Pasturefields Lane, Great Haywood, Autumn House and Manor House, Stafford Road, Stone, Staffordshire and all other current and future assets exists in respect of secured debts in favour of National Westminster Bank PLC. There is a cross guarantee between all group companies, including a first legal charge over Ashcroft Hollow Nursing Home, Stafford Road, Huntington, which is owned by Leacroft Lodge Limited.

17. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax
Accelerated capital allowances 761,115 756,560
On revaluation of properties 1,199,436 1,199,436
1,960,551 1,955,996

Deferred
tax
£   
Balance at 1 January 2025 1,955,996
Accelerated capital allowances 4,555
Balance at 31 December 2025 1,960,551

18. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
100 Ordinary £1 100 100

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

19. RESERVES
Retained Revaluation
earnings reserve Totals
£    £    £   

At 1 January 2025 4,465,607 4,468,122 8,933,729
Profit for the year 2,449,715 - 2,449,715
Dividends (811,419 ) - (811,419 )
At 31 December 2025 6,103,903 4,468,122 10,572,025

The revaluation reserve is solely attributable to the revaluation of freehold property.

20. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2025 and 31 December 2024:

2025 2024
£    £   
A K Haines
Balance outstanding at start of year 287,296 (178 )
Amounts advanced 902 287,474
Amounts repaid (300,000 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (11,802 ) 287,296

Interest is charged on the overdrawn directors loan account at 2.25%.

21. ULTIMATE CONTROLLING PARTY

The company is controlled by the Haines family, who wholly own and control Northgate Healthcare Holdings Limited, a company which owns 100% of the issued share capital of Northgate Healthcare Limited. Consolidated financial statements, in which this company is included, are publicly available from the Registrar of Companies, Cardiff.